These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35158249)

  • 21. Pharmacophore and docking-based combined in-silico study of KDR inhibitors.
    Pasha FA; Muddassar M; Neaz MM; Cho SJ
    J Mol Graph Model; 2009 Aug; 28(1):54-61. PubMed ID: 19447057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors.
    Halder AK; Saha A; Jha T
    J Pharm Pharmacol; 2013 Oct; 65(10):1541-54. PubMed ID: 24028622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New p-methylsulfonamido phenylethylamine analogues as class III antiarrhythmic agents: design, synthesis, biological assay, and 3D-QSAR analysis.
    Liu H; Ji M; Luo X; Shen J; Huang X; Hua W; Jiang H; Chen K
    J Med Chem; 2002 Jul; 45(14):2953-69. PubMed ID: 12086482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
    Chen M; Yang X; Lai X; Gao Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 3D-QSAR CoMSIA study on 3-azolylmethylindoles as anti-leishmanial agents.
    Giraud F; Loge C; Le Borgne M; Pagniez F; Na YM; Le Pape P
    SAR QSAR Environ Res; 2006 Jun; 17(3):299-309. PubMed ID: 16815769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors.
    Rebehmed J; Barbault F; Teixeira C; Maurel F
    J Comput Aided Mol Des; 2008 Nov; 22(11):831-41. PubMed ID: 18506577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective QSAR-Based Prediction Models with Pharmacophore Studies of Oxadiazole-Substituted α-Isopropoxy Phenylpropanoic Acids with Dual Activators of PPARα and PPARγ.
    Sharma MC
    Interdiscip Sci; 2015 Dec; 7(4):335-45. PubMed ID: 26178333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental and theoretical aspects of biochar-supported nanoscale zero-valent iron activating H
    Mao Q; Zhou Y; Yang Y; Zhang J; Liang L; Wang H; Luo S; Luo L; Jeyakumar P; Ok YS; Rizwan M
    J Hazard Mater; 2019 Dec; 380():120848. PubMed ID: 31319334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model.
    Ul-Haq Z; Ashraf S; Al-Majid AM; Barakat A
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
    Mondal C; Halder AK; Adhikari N; Jha T
    Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
    Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic-activated carbon composites derived from iron sludge and biological sludge for sulfonamide antibiotic removal.
    Wan J; Ding J; Tan W; Gao Y; Sun S; He C
    Environ Sci Pollut Res Int; 2020 Apr; 27(12):13436-13446. PubMed ID: 32026366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of quantitative structure activity relationship methods based on antitumor diarylsulfonylureas.
    Park Choo HY; Lim JS; Kam Y; Kim SY; Lee J
    Eur J Med Chem; 2001 Oct; 36(10):829-36. PubMed ID: 11738489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors.
    Patel PK; Bhatt HG
    Curr HIV Res; 2021; 19(2):154-171. PubMed ID: 33213349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
    Doddareddy MR; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Isoform-specific Binding Selectivities of Benzensulfonamides Using QSAR and 3D-QSAR.
    Raskevicius V; Kairys V
    Curr Comput Aided Drug Des; 2017; 13(1):75-83. PubMed ID: 27897106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.